The difference in trends between participants who completed the program (and showed a trend towards lowering of HbA1c measures) and those who did not complete the program (and showed a trend towards increasing HbA1c) may provide an incentive to find a path to undertake more robust co-designed clinical trials.
← all excerpts
Continuous Glucose Monitors and Programmed Shared Medical Appointments in Managing Type 2 Diabetes Mellitus Among First Nation Women in Australia: A Co-Designed Feasibility Study.
1
—
—